Joel Greenblatt's TERN Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 11,476 shares of Terns Pharmaceuticals, Inc. (TERN) worth $463,630, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in TERN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Terns Pharmaceuticals (TERN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Terns Pharmaceuticals (TERN) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +11,476 | New Buy | 11,476 | $40.40 |
Joel Greenblatt's Terns Pharmaceuticals Investment FAQs
Joel Greenblatt first purchased Terns Pharmaceuticals, Inc. (TERN) in Q4 2025, acquiring 11,476 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Terns Pharmaceuticals, Inc. (TERN) for 1 quarters since Q4 2025.
Joel Greenblatt's largest addition to Terns Pharmaceuticals, Inc. (TERN) was in Q4 2025, adding 11,476 shares worth $463,630.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 11,476 shares of Terns Pharmaceuticals, Inc. (TERN), valued at approximately $463,630.
As of the Q4 2025 filing, Terns Pharmaceuticals, Inc. (TERN) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Terns Pharmaceuticals, Inc. (TERN) was 11,476 shares, as reported at the end of Q4 2025.